These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23702602)

  • 1. The association of adipose-derived dimethylarginine dimethylaminohydrolase-2 with insulin sensitivity in experimental type 2 diabetes mellitus.
    Zheng J; Wang K; Jin P; Dong C; Yuan Q; Li Y; Yang Z
    Acta Biochim Biophys Sin (Shanghai); 2013 Aug; 45(8):641-8. PubMed ID: 23702602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of adipose tissue asymmetric dimethylarginine/dimethylarginine dimethylaminohydrolase pathway in adipose tissue phenotype and metabolic abnormalities in subtotally nephrectomized rats.
    Minakuchi H; Wakino S; Hosoya K; Sueyasu K; Hasegawa K; Shinozuka K; Yoshifuji A; Futatsugi K; Komatsu M; Kanda T; Tokuyama H; Hayashi K; Itoh H
    Nephrol Dial Transplant; 2016 Mar; 31(3):413-23. PubMed ID: 26516203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase.
    Lin KY; Ito A; Asagami T; Tsao PS; Adimoolam S; Kimoto M; Tsuji H; Reaven GM; Cooke JP
    Circulation; 2002 Aug; 106(8):987-92. PubMed ID: 12186805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyrrolidine dithiocarbamate ameliorates endothelial dysfunction in thoracic aorta of diabetic rats by preserving vascular DDAH activity.
    Lu CW; Lin Y; Lei YP; Wang L; He ZM; Xiong Y
    PLoS One; 2017; 12(7):e0179908. PubMed ID: 28715444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GC-MS assay for hepatic DDAH activity in diabetic and non-diabetic rats by measuring dimethylamine (DMA) formed from asymmetric dimethylarginine (ADMA): evaluation of the importance of S-nitrosothiols as inhibitors of DDAH activity in vitro and in vivo in humans.
    Chobanyan K; Thum T; Suchy MT; Zhu B; Mitschke A; Gutzki FM; Beckmann B; Stichtenoth DO; Tsikas D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 858(1-2):32-41. PubMed ID: 17825631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ex vivo gene transferring of human dimethylarginine dimethylaminohydrolase-2 improved endothelial dysfunction in diabetic rat aortas and high glucose-treated endothelial cells.
    Lu CW; Guo Z; Feng M; Wu ZZ; He ZM; Xiong Y
    Atherosclerosis; 2010 Mar; 209(1):66-73. PubMed ID: 19775692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing kidney DDAH-1 expression by adenovirus delivery reduces ADMA and ameliorates diabetic nephropathy.
    Wetzel MD; Gao T; Stanley K; Cooper TK; Morris SM; Awad AS
    Am J Physiol Renal Physiol; 2020 Feb; 318(2):F509-F517. PubMed ID: 31904280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effect of resveratrol derivative BTM-0512 on high glucose-induced cell senescence involves dimethylaminohydrolase/asymmetric dimethylarginine pathway.
    Yuan Q; Peng J; Liu SY; Wang CJ; Xiang DX; Xiong XM; Hu CP; Li YJ
    Clin Exp Pharmacol Physiol; 2010 May; 37(5-6):630-5. PubMed ID: 20132235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated onset of senescence of endothelial progenitor cells in patients with type 2 diabetes mellitus: role of dimethylarginine dimethylaminohydrolase 2 and asymmetric dimethylarginine.
    Yuan Q; Hu CP; Gong ZC; Bai YP; Liu SY; Li YJ; Jiang JL
    Biochem Biophys Res Commun; 2015 Mar; 458(4):869-76. PubMed ID: 25701782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dimethylarginine dimethylaminohydrolase (DDAH) regulates trophoblast invasion and motility through effects on nitric oxide.
    Ayling LJ; Whitley GS; Aplin JD; Cartwright JE
    Hum Reprod; 2006 Oct; 21(10):2530-7. PubMed ID: 16920729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pioglitazone lowers systemic asymmetric dimethylarginine by inducing dimethylarginine dimethylaminohydrolase in rats.
    Wakino S; Hayashi K; Tatematsu S; Hasegawa K; Takamatsu I; Kanda T; Homma K; Yoshioka K; Sugano N; Saruta T
    Hypertens Res; 2005 Mar; 28(3):255-62. PubMed ID: 16097370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for dysregulation of dimethylarginine dimethylaminohydrolase I in chronic hypoxia-induced pulmonary hypertension.
    Millatt LJ; Whitley GS; Li D; Leiper JM; Siragy HM; Carey RM; Johns RA
    Circulation; 2003 Sep; 108(12):1493-8. PubMed ID: 12952847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dimethylarginine dimethylaminohydrolase-2 overexpression improves impaired nitric oxide synthesis of endothelial cells induced by glycated protein.
    Lu CW; Xiong Y; He P
    Nitric Oxide; 2007 Feb; 16(1):94-103. PubMed ID: 16979918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of asymmetric dimethylarginine (ADMA) in tubulointerstitial ischaemia in the early phase of diabetic nephropathy.
    Shibata R; Ueda S; Yamagishi S; Kaida Y; Matsumoto Y; Fukami K; Hayashida A; Matsuoka H; Kato S; Kimoto M; Okuda S
    Nephrol Dial Transplant; 2009 Apr; 24(4):1162-9. PubMed ID: 19015171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymmetric dimethylarginine impairs glucose utilization via ROS/TLR4 pathway in adipocytes: an effect prevented by vitamin E.
    Yang ZC; Wang KS; Wu Y; Zou XQ; Xiang YY; Chen XP; Li YJ
    Cell Physiol Biochem; 2009; 24(1-2):115-24. PubMed ID: 19590199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basal release of nitric oxide in the mesenteric artery in portal hypertension and cirrhosis: role of dimethylarginine dimethylaminohydrolase.
    Serna E; Mauricio MD; Lluch P; Segarra G; Cortina B; Lluch S; Medina P
    J Gastroenterol Hepatol; 2013 May; 28(5):880-6. PubMed ID: 23302093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dimethylarginine dimethylaminohydrolase prevents progression of renal dysfunction by inhibiting loss of peritubular capillaries and tubulointerstitial fibrosis in a rat model of chronic kidney disease.
    Matsumoto Y; Ueda S; Yamagishi S; Matsuguma K; Shibata R; Fukami K; Matsuoka H; Imaizumi T; Okuda S
    J Am Soc Nephrol; 2007 May; 18(5):1525-33. PubMed ID: 17409314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of dimethylarginine dimethylaminohydrolase activity in regulation of tissue and plasma concentrations of asymmetric dimethylarginine in an animal model of prolonged critical illness.
    Davids M; Richir MC; Visser M; Ellger B; van den Berghe G; van Leeuwen PA; Teerlink T
    Metabolism; 2012 Apr; 61(4):482-90. PubMed ID: 22000584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The paraoxonase 1 (PON1), platelet-activating factor acetylohydrolase (PAF-AH) and dimethylarginine dimethylaminohydrolase (DDAH) activity in the metformin treated normal and diabetic rats.
    Wójcicka G; Jamroz-Wiśniewska A; Czechowska G; Korolczuk A; Marciniak S; Bełtowski J
    Eur J Pharmacol; 2016 Oct; 789():187-194. PubMed ID: 27450486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of NG,NG-dimethylarginine dimethylaminohydrolase and protein arginine N-methyltransferase isoforms in diabetic rat kidney: effects of angiotensin II receptor blockers.
    Onozato ML; Tojo A; Leiper J; Fujita T; Palm F; Wilcox CS
    Diabetes; 2008 Jan; 57(1):172-80. PubMed ID: 17909098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.